• Cue Biopharma was added to the Russell Microcap Index on June 29, 2026.
  • This follows earlier strategic developments including a $30 million private placement, an exclusive license for Ascendant-221, and significant board transitions, which continue to bolster investor confidence.
  • The stock is trading at $26.79, up 5.5% today.